Stafford I, Tomie A, Wagner G C
Drug Alcohol Depend. 1983 Oct;12(2):151-6. doi: 10.1016/0376-8716(83)90039-x.
The repeated administration of phencyclidine (PCP, 72 mg/kg/day) to rats led to physical dependence, as evidenced by a withdrawal syndrome exhibited approx. 24-48 h following suspension of drug. All components of the withdrawal syndrome were suppressed by s.c. injections of PCP (16 mg/kg), (+/-)-N-allylnormetazocine (SKF-10047, 16 mg/kg) and (+)-SKF-10047 (16 mg/kg), but not by injections of saline or (-)-SKF-10047. Moreover, tolerance to the behavioral effects of PCP, as well as cross-tolerance to (+/-)-SKF-10047 and (+)-SKF-10047 were observed. These data indicate that PCP and the sigma opiate SKF-10047 share mechanisms of action, which are mediated by the (+)-isomer of the sigma agonist.
对大鼠反复给予苯环己哌啶(PCP,72毫克/千克/天)会导致身体依赖,停药后约24 - 48小时出现的戒断综合征就是证据。皮下注射PCP(16毫克/千克)、(±)-N-烯丙基去甲左啡诺(SKF-10047,16毫克/千克)和(+)-SKF-10047(16毫克/千克)可抑制戒断综合征的所有症状,但注射生理盐水或(-)-SKF-10047则无此效果。此外,还观察到对PCP行为效应的耐受性以及对(±)-SKF-10047和(+)-SKF-10047的交叉耐受性。这些数据表明,PCP和西格玛阿片类药物SKF-10047具有共同的作用机制,该机制由西格玛激动剂的(+)-异构体介导。